View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsAgroFresh Solutions 配当と自社株買い配当金 基準チェック /06主要情報n/a配当利回り-0.2%バイバック利回り総株主利回り-0.2%将来の配当利回り0%配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesReported Earnings • Mar 11Full year 2022 earnings released: US$1.15 loss per share (vs US$0.59 loss in FY 2021)Full year 2022 results: US$1.15 loss per share (further deteriorated from US$0.59 loss in FY 2021). Revenue: US$161.9m (down 2.4% from FY 2021). Net loss: US$59.8m (loss widened 97% from FY 2021). Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.Buying Opportunity • Nov 19Now 20% undervaluedOver the last 90 days, the stock is up 50%. The fair value is estimated to be €3.34, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 4.9%. For the next 3 years, revenue is forecast to grow by 10% per annum. Earnings is also forecast to grow by 30% per annum over the same time period.Board Change • Nov 16High number of new directorsThere are 7 new directors who have joined the board in the last 3 years. Director David McInerney was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Buying Opportunity • Nov 11Now 22% undervaluedOver the last 90 days, the stock is up 47%. The fair value is estimated to be €3.38, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 10%. For the next 3 years, revenue is forecast to grow by 10% per annum. Earnings is also forecast to grow by 24% per annum over the same time period.Reported Earnings • Aug 11Second quarter 2022 earnings released: US$0.47 loss per share (vs US$0.46 loss in 2Q 2021)Second quarter 2022 results: US$0.47 loss per share (down from US$0.46 loss in 2Q 2021). Revenue: US$25.8m (up 18% from 2Q 2021). Net loss: US$24.5m (loss widened 4.1% from 2Q 2021). Over the next year, revenue is forecast to grow 5.6%, compared to a 3.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 10% per year, which means it is tracking significantly ahead of earnings growth.Recent Insider Transactions • May 25CEO & Director recently bought €88k worth of stockOn the 20th of May, Clinton Lewis bought around 53k shares on-market at roughly €1.64 per share. This was the largest purchase by an insider in the last 3 months. This was Clinton's only on-market trade for the last 12 months.Reported Earnings • May 13First quarter 2022 earnings released: US$0.18 loss per share (vs US$0.029 profit in 1Q 2021)First quarter 2022 results: US$0.18 loss per share (down from US$0.029 profit in 1Q 2021). Revenue: US$39.9m (up 2.3% from 1Q 2021). Net loss: US$9.52m (down US$11.0m from profit in 1Q 2021). Over the next year, revenue is forecast to grow 6.5%, compared to a 6.4% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 10% per year.Board Change • Apr 27High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Mar 11Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: US$0.59 loss per share (up from US$1.27 loss in FY 2020). Revenue: US$166.0m (up 5.3% from FY 2020). Net loss: US$30.3m (loss narrowed 53% from FY 2020). Revenue exceeded analyst estimates by 1.7%. Over the next year, revenue is forecast to grow 6.1%, compared to a 4.8% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 16% per year.Reported Earnings • Nov 11Third quarter 2021 earnings released: US$0.10 loss per share (vs US$0.52 loss in 3Q 2020)The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2021 results: Revenue: US$49.2m (down 6.8% from 3Q 2020). Net loss: US$5.25m (loss narrowed 80% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 27% per year, which means it has not declined as severely as earnings.Board Change • Nov 01High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Board Change • Oct 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 11Second quarter 2021 earnings released: US$0.46 loss per share (vs US$0.33 loss in 2Q 2020)The company reported a soft second quarter result with increased losses and weaker control over costs, although revenues improved. Second quarter 2021 results: Revenue: US$21.9m (up 9.7% from 2Q 2020). Net loss: US$23.6m (loss widened 43% from 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.Executive Departure • Jun 16Independent Investor Director Peter Berweger has left the companyOn the 11th of June, Peter Berweger's tenure as Independent Investor Director ended after less than a year in the role. We don't have any record of a personal shareholding under Peter's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 1.50 years, which is considered inexperienced in the Simply Wall St Risk Model.Reported Earnings • May 15First quarter 2021 earnings released: EPS US$0.047 (vs US$0.072 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$39.0m (up 18% from 1Q 2020). Net income: US$2.42m (up US$6.07m from 1Q 2020). Profit margin: 6.2% (up from net loss in 1Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 34 percentage points per year, which is a significant difference in performance.Analyst Estimate Surprise Post Earnings • Mar 12Revenue misses expectationsRevenue missed analyst estimates by 1.9%. Over the next year, revenue is forecast to grow 5.9%, compared to a 6.0% growth forecast for the Chemicals industry in Germany.Reported Earnings • Mar 12Full year 2020 earnings released: US$1.26 loss per share (vs US$1.21 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: US$157.6m (down 7.3% from FY 2019). Net loss: US$64.2m (loss widened 5.5% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 84% per year but the company’s share price has only fallen by 29% per year, which means it has not declined as severely as earnings.Executive Departure • Feb 25Independent Director has left the companyOn the 18th of February, George Lobisser's tenure as Independent Director ended after 4.4 years in the role. As of December 2020, George personally held 146.91k shares (€282k worth at the time). George is the only executive to leave the company over the last 12 months.Is New 90 Day High Low • Jan 08New 90-day low: €1.69The company is down 24% from its price of €2.22 on 09 October 2020. The German market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €2.47 per share.Analyst Estimate Surprise Post Earnings • Nov 07Revenue misses expectationsRevenue missed analyst estimates by 18%. Over the next year, revenue is forecast to grow 6.9%, compared to a 2.8% growth forecast for the Chemicals industry in Germany.Reported Earnings • Nov 07Third quarter 2020 earnings released: US$0.52 loss per shareThe company reported a soft third quarter result with weaker earnings and control over expenses, although revenues were improved. Third quarter 2020 results: Revenue: US$52.8m (up 7.8% from 3Q 2019). Net loss: US$26.3m (down US$29.6m from profit in 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings.Is New 90 Day High Low • Oct 24New 90-day low: €1.91The company is down 5.0% from its price of €2.02 on 24 July 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €6.73 per share.決済の安定と成長配当データの取得安定した配当: 35Xの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: 35Xの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場AgroFresh Solutions 配当利回り対市場35X 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (35X)n/a市場下位25% (DE)1.5%市場トップ25% (DE)4.6%業界平均 (Chemicals)3.8%アナリスト予想 (35X) (最長3年)0%注目すべき配当: 35Xは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: 35Xは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: 35Xの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: 35Xが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YDE 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2023/04/03 13:09終値2023/03/30 00:00収益2022/12/31年間収益2022/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋AgroFresh Solutions, Inc. 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関Joel JacksonBMO Capital Markets Equity ResearchAmit DayalH.C. Wainwright & Co.Benjamin KlieveLake Street Capital Markets, LLC1 その他のアナリストを表示
Reported Earnings • Mar 11Full year 2022 earnings released: US$1.15 loss per share (vs US$0.59 loss in FY 2021)Full year 2022 results: US$1.15 loss per share (further deteriorated from US$0.59 loss in FY 2021). Revenue: US$161.9m (down 2.4% from FY 2021). Net loss: US$59.8m (loss widened 97% from FY 2021). Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.
Buying Opportunity • Nov 19Now 20% undervaluedOver the last 90 days, the stock is up 50%. The fair value is estimated to be €3.34, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 4.9%. For the next 3 years, revenue is forecast to grow by 10% per annum. Earnings is also forecast to grow by 30% per annum over the same time period.
Board Change • Nov 16High number of new directorsThere are 7 new directors who have joined the board in the last 3 years. Director David McInerney was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Buying Opportunity • Nov 11Now 22% undervaluedOver the last 90 days, the stock is up 47%. The fair value is estimated to be €3.38, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 10%. For the next 3 years, revenue is forecast to grow by 10% per annum. Earnings is also forecast to grow by 24% per annum over the same time period.
Reported Earnings • Aug 11Second quarter 2022 earnings released: US$0.47 loss per share (vs US$0.46 loss in 2Q 2021)Second quarter 2022 results: US$0.47 loss per share (down from US$0.46 loss in 2Q 2021). Revenue: US$25.8m (up 18% from 2Q 2021). Net loss: US$24.5m (loss widened 4.1% from 2Q 2021). Over the next year, revenue is forecast to grow 5.6%, compared to a 3.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 10% per year, which means it is tracking significantly ahead of earnings growth.
Recent Insider Transactions • May 25CEO & Director recently bought €88k worth of stockOn the 20th of May, Clinton Lewis bought around 53k shares on-market at roughly €1.64 per share. This was the largest purchase by an insider in the last 3 months. This was Clinton's only on-market trade for the last 12 months.
Reported Earnings • May 13First quarter 2022 earnings released: US$0.18 loss per share (vs US$0.029 profit in 1Q 2021)First quarter 2022 results: US$0.18 loss per share (down from US$0.029 profit in 1Q 2021). Revenue: US$39.9m (up 2.3% from 1Q 2021). Net loss: US$9.52m (down US$11.0m from profit in 1Q 2021). Over the next year, revenue is forecast to grow 6.5%, compared to a 6.4% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 10% per year.
Board Change • Apr 27High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Mar 11Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: US$0.59 loss per share (up from US$1.27 loss in FY 2020). Revenue: US$166.0m (up 5.3% from FY 2020). Net loss: US$30.3m (loss narrowed 53% from FY 2020). Revenue exceeded analyst estimates by 1.7%. Over the next year, revenue is forecast to grow 6.1%, compared to a 4.8% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 16% per year.
Reported Earnings • Nov 11Third quarter 2021 earnings released: US$0.10 loss per share (vs US$0.52 loss in 3Q 2020)The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2021 results: Revenue: US$49.2m (down 6.8% from 3Q 2020). Net loss: US$5.25m (loss narrowed 80% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 27% per year, which means it has not declined as severely as earnings.
Board Change • Nov 01High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Board Change • Oct 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director John Atkin was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 11Second quarter 2021 earnings released: US$0.46 loss per share (vs US$0.33 loss in 2Q 2020)The company reported a soft second quarter result with increased losses and weaker control over costs, although revenues improved. Second quarter 2021 results: Revenue: US$21.9m (up 9.7% from 2Q 2020). Net loss: US$23.6m (loss widened 43% from 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.
Executive Departure • Jun 16Independent Investor Director Peter Berweger has left the companyOn the 11th of June, Peter Berweger's tenure as Independent Investor Director ended after less than a year in the role. We don't have any record of a personal shareholding under Peter's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 1.50 years, which is considered inexperienced in the Simply Wall St Risk Model.
Reported Earnings • May 15First quarter 2021 earnings released: EPS US$0.047 (vs US$0.072 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$39.0m (up 18% from 1Q 2020). Net income: US$2.42m (up US$6.07m from 1Q 2020). Profit margin: 6.2% (up from net loss in 1Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 34 percentage points per year, which is a significant difference in performance.
Analyst Estimate Surprise Post Earnings • Mar 12Revenue misses expectationsRevenue missed analyst estimates by 1.9%. Over the next year, revenue is forecast to grow 5.9%, compared to a 6.0% growth forecast for the Chemicals industry in Germany.
Reported Earnings • Mar 12Full year 2020 earnings released: US$1.26 loss per share (vs US$1.21 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: US$157.6m (down 7.3% from FY 2019). Net loss: US$64.2m (loss widened 5.5% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 84% per year but the company’s share price has only fallen by 29% per year, which means it has not declined as severely as earnings.
Executive Departure • Feb 25Independent Director has left the companyOn the 18th of February, George Lobisser's tenure as Independent Director ended after 4.4 years in the role. As of December 2020, George personally held 146.91k shares (€282k worth at the time). George is the only executive to leave the company over the last 12 months.
Is New 90 Day High Low • Jan 08New 90-day low: €1.69The company is down 24% from its price of €2.22 on 09 October 2020. The German market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €2.47 per share.
Analyst Estimate Surprise Post Earnings • Nov 07Revenue misses expectationsRevenue missed analyst estimates by 18%. Over the next year, revenue is forecast to grow 6.9%, compared to a 2.8% growth forecast for the Chemicals industry in Germany.
Reported Earnings • Nov 07Third quarter 2020 earnings released: US$0.52 loss per shareThe company reported a soft third quarter result with weaker earnings and control over expenses, although revenues were improved. Third quarter 2020 results: Revenue: US$52.8m (up 7.8% from 3Q 2019). Net loss: US$26.3m (down US$29.6m from profit in 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings.
Is New 90 Day High Low • Oct 24New 90-day low: €1.91The company is down 5.0% from its price of €2.02 on 24 July 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €6.73 per share.